EWSR1 and Ewing sarcoma: Therefore, further advancement in animal modelling and cancer-related genetic modification (such as EWS/ETS target genes) of ES by CRISPR/Cas9 technology is needed, and it is expected to provide more options for clinical treatment of ES.